Anticoagulant Therapy in Moderate to Severe COVID-19 Patients

Anticoagulant Therapy in Moderate to Severe COVID-19 Patients

Coronavirus disease-19 (COVID-19) has a spectrum of severity from no symptoms to serious complications. Coagulopathy is a serious complication of COVID-19, and that condition is a marker of poor prognosis. Anticoagulant drugs are often used as prophylaxis and thrombosis therapy to treat COVID-19 pat...

Full description

Bibliographic Details
Main Authors: Agus Fitriyanto Achmad, Yuni Iswati Raharjani, Zidni Setyaningrum, Bagus Andi Pramono, Dita Ria Selvyana, Sri Pramesthi Wisnu Bowo Negoro
Format: Article
Language:English
Published: Universitas Muhammadiyah Yogyakarta 2022-01-01
Series:Mutiara Medika
Subjects:
anticoagulant
coagulopathy
covid-19
low-molecular-weight heparin
unfractionated heparin
Online Access:https://journal.umy.ac.id/index.php/mm/article/view/11634

Internet

https://journal.umy.ac.id/index.php/mm/article/view/11634

Similar Items